epirubicin has been researched along with Cancer of Pharynx in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, YJ; Guo, X; Guo, Y; Lu, H; Ma, X; Pang, Z; Wang, B | 1 |
| Barabás, J; Cséplo, K; Németh, Z; Szabó, G; Szigeti, K; Vaszilkó, M; Velich, N | 1 |
1 trial(s) available for epirubicin and Cancer of Pharynx
| Article | Year |
|---|---|
A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Invasiveness; Nose Neoplasms; Pharyngeal Neoplasms; Prednisone; Prognosis; Radiation Injuries; Semustine; Survival Rate; Vincristine; Young Adult | 2009 |
1 other study(ies) available for epirubicin and Cancer of Pharynx
| Article | Year |
|---|---|
[Survival prospects of mesopharyngeal carcinoma patients treated primarily with intraarterial chemotherapy. A retrospective study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Leucovorin; Male; Methotrexate; Middle Aged; Pharyngeal Neoplasms; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2006 |